CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 24 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,139,000 | -10.9% | 6,138,000 | +3.5% | 0.02% | -8.7% |
| Q4 2017 | $8,009,000 | -59.6% | 5,930,000 | -53.8% | 0.02% | -60.3% |
| Q3 2017 | $19,835,000 | -35.9% | 12,828,000 | -29.7% | 0.06% | -37.0% |
| Q2 2017 | $30,967,000 | +68.1% | 18,243,000 | +28.0% | 0.09% | +67.3% |
| Q1 2017 | $18,417,000 | +207.3% | 14,249,000 | +298.1% | 0.06% | +205.6% |
| Q3 2015 | $5,993,000 | – | 3,579,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 70,125,000 | $118,981,000 | 5.01% |
| PFM Health Sciences, LP | 46,790,999 | $79,428,000 | 2.14% |
| Partner Investment Management, L.P. | 790,001 | $1,341,000 | 1.80% |
| Myriad Asset Management Ltd. | 10,000,000 | $16,984,000 | 1.18% |
| CSS LLC/IL | 10,950,000 | $18,558,000 | 0.90% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $15,403,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 2,784,000 | $4,715,000 | 0.42% |
| ZAZOVE ASSOCIATES LLC | 4,030,000 | $6,833,000 | 0.36% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,826,000 | $13,277,000 | 0.25% |
| LORD, ABBETT & CO. LLC | 18,243,000 | $30,967,000 | 0.09% |